FIRST ON FOX: Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human ...
Office of Prescription Drug Promotion (OPDP) has stepped up its enforcement efforts regarding prescription drug promotion, ...
Add Yahoo as a preferred source to see more of our stories on Google. The United States is one of just two countries where drugmakers can advertise directly to patients. BrianAJackson/iStock via Getty ...
Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump is ramping up pressure on drug companies to be more transparent about the risks associated with their prescription ...
President Donald Trump is aiming to ramp up scrutiny on pharmaceutical ads — both on TV and social media — as his administration accuses companies of misleading the public about medications and their ...
HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, MD, MPH, would seemingly like us to believe that they are strong-arming pharmaceutical companies into ending misleading marketing ...
On September 9, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued numerous untitled letters as part of the agency’s wider attack on direct to ...
The bill would only prohibit direct-to-consumer advertising of approved prescription pharmaceuticals and biologics, sparing medical devices, dietary supplements, cosmetics, over-the-counter drugs, ...
President Donald Trump signed an order Tuesday aimed at tightening restrictions on direct-to-consumer drug advertising, expanding his administration’s scrutiny against big pharmaceutical companies and ...
WASHINGTON — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including ...